Australia Drug-Benefit Plan Snubs Drugs Without Delivery Support
This article was originally published in PharmAsia News
Executive Summary
Australia's program for subsidizing the cost of certain drugs rejected for coverage for patients with Parkinson's disease because the equipment to deliver has not been approved for funding